Metal‐DNA Nanocomplexes Enhance Chemo‐dynamic Therapy by Inhibiting Autophagy‐Mediated Resistance

Abstract

Chemo‐dynamic therapy (CDT) based on the Fenton or Fenton‐like reaction has emerged as a promising approach for cancer treatment. However, autophagy‐mediated self‐protection mechanisms of cancer cells pose a significant challenge to the efficacy of CDT. Herein, we developed metal‐DNA nanocomplexes (DACs‐Mn) to enhance CDT via DNAzyme inhibition of autophagy. Specifically, Mn‐based catalyst in DACs‐Mn was used to generate highly hydroxyl radicals (⋅OH) that kill cancer cells, while the ATG5 DNAzyme incorporated into DACs‐Mn inhibited the expression of autophagy‐associated proteins, thereby improving the efficacy of CDT. By disrupting the self‐protective pathway of cells under severe oxidative stress, this novel approach of DACs‐Mn was found to synergistically enhance CDT in both in vitro and in vivo models, effectively amplifying tumor‐specific oxidative damage. Notably, the Metal‐DNA nanocomplexes can also induce immunogenic cell death (ICD), thereby inhibiting tumor metastasis. Specifically, in a bilateral tumor model in mice, the combined approach of CDT and autophagy inhibition followed by immune checkpoint blockade therapy shown significant potential as a novel and effective treatment modality for primary and metastatic tumors.